Acceleron Pharma Inc (XLRN) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Sep 30 2021 to Sep 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Acceleron Pharma inc  (NASDAQ: XLRN)


Acceleron Pharma Inc's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Acceleron Pharma Inc's ROI in the third quarter of 2021?
Acceleron Pharma Inc recorded a cumulative net loss of $-255 million during 12 months ending in the third quarter of 2021, resulting in a negative return on investment (ROI) of -31.8%.

Within the Healthcare sector 496 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 0 to 3810.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Investment Change TTM 41.84 % 84.25 % 58.89 % 31.61 % 22.42 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 730 777 826 872 910
Return On Investment (TTM) -31.8 % -26.42 % -23.41 % -24.96 % -23.4 %
XLRN's Overall Ranking # 3810 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -5.32 % 10.96 % 14.67 % 17.73 % 22.99 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -255 -224 -179 -166 -132

XLRN Company Profile >> Back to XLRN Roi Comparisons >> See Annual XLRN Return On Investment



Return On Investment XLRN's Ranking
Within: No.
Industry # 72
Sector # 497
Overall # 3810

Return On Investment Statistics
High Average Low
-22.51 %
-30.99 %
-42.94 %
(Dec 31 2016)   (Jun 30 2017)







Financial Statements
Acceleron Pharma Inc's III. Quarter Investments $ 730 Millions XLRN's Balance sheet
Acceleron Pharma Inc's III. Quarter Income $ -70 Millions Quarterly XLRN's Income Statement
XLRN's Income by Division See XLRN's Income by Division


XLRN Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 872 472 296 372 231
Y / Y Investment Growth 84.97 % 59.35 % -20.55 % 60.88 % 75.58 %
Net Income in Millions -166 -125 -119 -108 -57
Y / Y Net Income Growth - - - - -
Annual Return On Investment -19.04 % -26.48 % -40.17 % -29.12 % -24.63 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XLRN's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XLRN's Competitors
Subscribers only: Roi for Acceleron Pharma Inc's Suppliers
Subscribers only: Return On Investment for XLRN's Customers

Other Ratios
XLRN's Roa XLRN's Inventory Turnover Ratio XLRN's Growth Rates XLRN's Dividend Statistics
XLRN's Profitability Ratios XLRN's Asset Turnover Ratio XLRN's Dividend Growth
XLRN's Roe XLRN's Valuation Ratios XLRN's Financial Strength Ratios XLRN's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2021, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.